Sort   by:  
 Page size 
UnknownSafety and efficacy of meplazumab in healthy volunteers and COVID-19 patients: a randomized phase 1 and an exploratory phase 2 trial.
Not available
S-EPMC8127508 | biostudies-literature
UnknownInducible CD147 up-regulation boosts extended SARS-CoV-2 infection triggering severe COVID-19 independent of ACE2.
Not available
S-EPMC12864993 | biostudies-literature
UnknownMeplazumab, a CD147 antibody, for severe COVID-19: a double-blind, randomized, placebo-controlled, phase 3 clinical trial.
Not available
S-EPMC11994814 | biostudies-literature
Sort   by:  
 Page size